Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)

Phase 1
Completed
Conditions
Pulmonary Arterial Hypertension
Interventions
Drug: Sorafenib
First Posted Date
2007-03-27
Last Posted Date
2016-08-24
Lead Sponsor
University of Chicago
Target Recruit Count
12
Registration Number
NCT00452218
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

Phase 1
Completed
Conditions
Advanced Solid Tumor
Interventions
Drug: Sorafenib
Drug: Rapamycin
First Posted Date
2007-03-20
Last Posted Date
2013-06-12
Lead Sponsor
University of Chicago
Target Recruit Count
34
Registration Number
NCT00449280
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Early Indicators of Chronic Rejection in Lung Transplant

First Posted Date
2007-03-20
Last Posted Date
2016-09-20
Lead Sponsor
University of Chicago
Target Recruit Count
120
Registration Number
NCT00449332
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

Phase 4
Terminated
Conditions
Pulmonary Hypertension
First Posted Date
2006-12-11
Last Posted Date
2014-06-02
Lead Sponsor
University of Chicago
Target Recruit Count
1
Registration Number
NCT00409526
Locations
🇮🇱

Shaare Zedek Medical Center, Jerusalem, Israel

🇺🇸

Comer Children's Hospital, The University of Chicago Hospitals, Chicago, Illinois, United States

Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery

First Posted Date
2006-12-04
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
37
Registration Number
NCT00406913
Locations
🇺🇸

University of Chicago Hospitals, Chicago, Illinois, United States

Bangladesh Vitamin E and Selenium Trial

First Posted Date
2006-10-26
Last Posted Date
2023-04-26
Lead Sponsor
University of Chicago
Target Recruit Count
7000
Registration Number
NCT00392561
Locations
🇧🇩

Columbia University Arsenic Research Project, Dhaka, Bangladesh

🇧🇩

ICDDR,B, Dhaka, Bangladesh

Rapamycin With Grapefruit Juice for Advanced Malignancies

First Posted Date
2006-09-12
Last Posted Date
2014-01-17
Lead Sponsor
University of Chicago
Target Recruit Count
41
Registration Number
NCT00375245
Locations
🇺🇸

University of Chicago Hospitals, Chicago, Illinois, United States

Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

Phase 4
Terminated
Conditions
Seasonal Allergic Rhinitis
Interventions
Drug: Placebo
Drug: Mometasone
First Posted Date
2006-08-08
Last Posted Date
2014-02-28
Lead Sponsor
University of Chicago
Target Recruit Count
17
Registration Number
NCT00361439
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Improving Diabetes Care Collaboratively in the Community

First Posted Date
2006-08-03
Last Posted Date
2016-04-12
Lead Sponsor
University of Chicago
Target Recruit Count
6993
Registration Number
NCT00359996
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

N-Acetyl Cysteine in Trichotillomania

Phase 2
Completed
Conditions
Trichotillomania
Interventions
Drug: N-Acetyl Cysteine
Drug: Placebo
First Posted Date
2006-07-20
Last Posted Date
2023-02-23
Lead Sponsor
University of Chicago
Target Recruit Count
50
Registration Number
NCT00354770
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy